| Literature DB >> 35223574 |
Dariush Farhud1,2,3, Rojiar Asgarian4, Amelia Seifalian5,6, Paria Mostafaeinejad7,8, Maryam Eslami7,8.
Abstract
BACKGROUND: Turner syndrome (TS), also known as 45,X, is a genetic disorder caused by the partial or complete lack of an X chromosome. TS can cause a variety of medical and developmental conditions. We aimed to investigate TS mosaicism and variants pattern and research the presence of a correlation between the different variant's factors and TS occurrence.Entities:
Keywords: Chromosomal disorders; Primary amenorrhea; Turner syndrome; X chromosome
Year: 2021 PMID: 35223574 PMCID: PMC8819239 DOI: 10.18502/ijph.v50i10.7507
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
Turner mosaicism and variants
|
|
|
|
|---|---|---|
| 45,X / 46,XX | 50 | 45.04 |
| 45,X / 46,XY | 12 | 10.81 |
| 45,X / 46,XX / 47, XXX | 11 | 9.90 |
| 45,X / 46, X (r)X | 6 | 5.40 |
| 46, X, i (Xq) | 6 | 5.40 |
| 45,X / 47, XXX | 5 | 4.50 |
| 45,X / 46, X, i (Xq) | 5 | 4.50 |
| 45, X / 46, XX / 47, XXX / 48, XXXX | 3 | 2.70 |
| 45, X / 46, X (r)Y | 2 | 1.80 |
| 45, X / 46, X, del (Xq) | 1 | 0.90 |
| 45, X / 46, XX / 48, XXXX | 1 | 0.90 |
| 45, X / 46, X, del (Xp) | 1 | 0.90 |
| 45, X / 46, X, r, i (Xq) | 1 | 0.90 |
| 45, XX | 1 | 0.90 |
| 45, X, inv ( | 1 | 0.90 |
| 45, X, inv ( | ||
| 45, X / 46, X, tas (X:X) / (p22.3; p22.3) | 1 | 0.90 |
| 46, X, iX | 1 | 0.90 |
| 46, XX, del (Xq) | 1 | 0.90 |
| Unspecific karyotype | 1 | 0.90 |
| Total | 111 |
Data obtained from the patients’ documents that underwent karyotyping
Pts: Patients
The reason of referring to the physician (n=209)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of pts | 95 | 52 | 19 | 8 | 7 | 6 | 6 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Percentage | 45.45 | 24.8 | 9.0 9 | 3.8 | 3.3 | 2.8 | 2.8 | 1.43 | 0.95 | 0.95 | 0.95 | 0.95 | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 |
Pts: Patients
The order of children (n=140)
|
|
|
|
|
|
|---|---|---|---|---|
| Number of pts | 61 | 51 | 20 | 8 |
| Percentage | 43.57 | 36.43 | 14.29 | 5.71 |
Data obtained from the patients’ documents that underwent karyotyping
Pts: Patients
Patient’s age by referring to physician (n=36)
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of pts | 5 | 0 | 2 | 4 | 3 | 7 | 5 | 7 | 2 | 1 | 0 |
| Percentage | 13.8 | 0 | 5.5 | 11.11 | 16.6 | 19.4 | 13.8 | 19.4 | 5.5 | 2.7 | 0 |
Pts: Patients
Maternal age and its correlation with TS (n=108)
|
|
|
|
|
|---|---|---|---|
| Number of Patients with TS | 9 | 35 | 64 |
| Percentage | 8.33 | 32.41 | 59.26 |
Paternal age and its correlation with TS (n=90)
|
|
|
|
|
|---|---|---|---|
| Number of pts with TS | 1 | 18 | 71 |
| Percentage | 1.11 | 20 | 78.89 |
Pts: Patients
Marriage (n=144)
|
|
|
|
|---|---|---|
| Number of pts | 55 | 88 |
| Percentage | 38.46 | 61.54 |
| Percentage of Iranian Data (49) | 38.60 | 61.40 |
Type (consanguineous and non-consanguineous in patients compared to previous study done on Iranian population (49)
Pts: Patients
Fig. 1:Turner 45,X and 46,XY karyotype UPGMA dendrogram based on gender. (A) 45,X turner karyotype UPGMA dendrogram; (B) 46,XY turner karyotype UPGMA dendrogram
Present the internal and external studies
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| Mashhad | 50% of cases were 45X, 22.5% mosaic and 15% isochromosome ( | 7 | 40 | 2003 |
| Tehran | The karyotype 45 X (full monosomal X) was the most commonly observed karyotype (111 cases, 45.7%), then karyotypes 46XX / 45X (33 cases, 13.6%) isoXq, XX46 / 45X (25 cases, 3.10%) and isoXq / 45X (23 cases, 9.5%). 12 patients (4.9%) with cell line, 46XY. ( | 30 | 243 | 2004 | |
| Tehran | These patients were referred to the Endocrinology and Metabolism Institute ( | 1 | 35 | 2005 | |
| Iran | Of the patients studied, 37.5% had a classical karyotype of 45% and 62.5%of the remaining mosaic or structural disorders in the second sex chromosome ( | 5 | 40 | 2006 | |
|
| Sweden | 44%exhibited a 45,X karyotype and56% a second-cell line, while 27% of all hada45,X/46,XX mosaicism. Five 45,X cases with a conventional karyotype were 45,X/46,XX mosaic according to FISH ( | - | 126 | 2007 |
| Denmark | 45,X (n=64); 45,X/46,XX (n=8); karyotypes with isochromosomes (IsoXq) (n=23) and deletions (n=2); karyotypes with Y chromosomal material (n=5); and karyotypes with marker or ring chromosomes (n = 5) ( | - | 107 | 2009 | |
| Brazil | 25.6% of patients presented CV abnormalities which 21.4%, 19% and 19% of them suffered from mitral regurgitation, bicuspid aortic valve and aortic coarctation, respectively. ( | 17 | 130 | 2010 | |
| Sweden | Women who gave birth to girls with Turner syndrome: maternal and neonatal characteristics ( | 39 | - | 2010 | |
| Portugal | Karyotype: X monosomy-37/2%, mosaicism-37/2%, X structural changes-25/6%. Median FSH of 59/05 mIU/mL ( | - | 79 | 2013 | |
| Italy | X-monosomy (77.5)X mosaicism with structural abnormalities of the second X (7.5)X-mosaicism without structural abnormalities of the second X (12.5) Structural abnormalities of the second X (2.5) ( | 1 | 40 | 2014 | |
| Albania | The most frequent pathologies are thyroid autoimmune disorders, cardiovascular anomalies, renal pathologies, hearing impairment and hypertension, 59%, 43%, 41%, 4.3% and 3,3% ( | 5 | 52 | 2015 | |
| Sweden | 64 women with TS between 25–38 yr old. 52% suffering from impaired hearing in at least one ear. ( | - | 64 | 2017 |
Keys: NOS: number of samples, SP: study period in year
45,X/46,XY mosaicisms cases (n=12)
|
|
|
|
|
|
|---|---|---|---|---|
| 1 | Blind | Male | 75 | 25 |
| 2 | - | Male | 20 | 80 |
| 3 | - | Female | 70 | 30 |
| 4 | Short stature | Female | 30 | 70 |
| 5 | Cryptorchidism | Male | 60 | 40 |
| 6 | Sexual ambiguity | Male | 80 | 20 |
| 7 | Primary amenorrhea | Female | 30 | 70 |
| 8 | Primary amenorrhea - Not growing | Female | 75 | 25 |
| 9 | Sexual ambiguity | Female | 80 | 20 |
| 10 | Low Growth | Male | 80 | 20 |
| 11 | Sexual ambiguity genitalia | ambiguous genitalia | 10 | 90 |
| 12 | Primary amenorrhea | Female | 70 | 30 |
Data obtained from the patient’s documents that underwent karyotyping